How should menopausal status be assessed using serum follicle‑stimulating hormone (FSH) levels in a woman taking a progestin‑only contraceptive pill?

How to Assess Menopausal Status with FSH Level in Someone on Progestin-Only Pill

You must discontinue the progestin-only pill for at least 3 months before measuring FSH to accurately assess menopausal status, as progestins with antigonadotropic action significantly suppress FSH levels and render the test unreliable. 1

The Core Problem

Progestin-only pills (POPs) interfere with FSH measurement accuracy because they exert antigonadotropic effects that suppress gonadotropin secretion. This means FSH levels will be artificially low while taking the medication, making it impossible to determine true menopausal status 1.

Recommended Assessment Algorithm

Step 1: Discontinue the Progestin-Only Pill

• Stop the POP for at least 3 months before attempting FSH measurement 1
• This washout period allows the hypothalamic-pituitary-ovarian axis to recover from hormonal suppression
• Use barrier contraception during this period if pregnancy prevention is still needed

Step 2: Measure FSH and Estradiol

After the 3-month washout:

• Obtain two FSH measurements at least 1 month apart 1
• Measure estradiol simultaneously with each FSH test
• FSH >25 IU/L indicates postmenopausal status (some guidelines use >35 IU/L, but the threshold has been lowered as autoimmune POI often shows levels between 25-35 IU/L) 1
• Low estradiol (<20 pg/mL) supports the diagnosis 2

Step 3: Interpret Results Carefully

• Require at least two consecutive elevated FSH measurements to confirm menopause 1, 3
• This is critical because approximately 40% of women with one elevated FSH will have normal levels on subsequent testing 3
• A single elevated FSH is insufficient for diagnosis

Age-Specific Considerations

For women ≥60 years: Menopause can be presumed based on age alone without FSH testing 4, 5

For women 50-59 years:

• If amenorrheic for ≥12 months off hormonal contraception, menopause can be diagnosed clinically
• FSH confirmation helpful but not mandatory 4

For women <50 years:

• FSH testing is more important as premature ovarian insufficiency must be distinguished from perimenopause
• Serial measurements are essential 4, 5

Alternative Approach for Injectable Progestins

If the patient is using depot medroxyprogesterone acetate (DMPA) rather than oral POPs, FSH can be measured without discontinuing the method, though interpretation differs:

• Measure FSH immediately before the next scheduled injection 3, 6
• Elevated FSH can be detected during DMPA use 6
• Still require two consecutive elevated measurements due to fluctuation 3
• This approach is most reliable in women ≥50 years 3

Critical Pitfalls to Avoid

1. Never measure FSH while actively taking oral progestin-only pills - the results will be falsely low and misleading 1

2. Don't rely on amenorrhea alone - progestin-induced amenorrhea does not indicate menopausal status 4, 5

3. Don't accept a single elevated FSH - fluctuations are common and 40% will normalize on repeat testing 3

4. Don't confuse macro-progestins with low-dose POPs - combined estrogen-progestin contraception and macro-progestins with strong antigonadotropic action require the full 3-month washout 1

When FSH Testing Cannot Establish Menopausal Status

It is not possible to assign menopausal status to women receiving LHRH agonists or antagonists regardless of FSH levels 4, 5. In women with chemotherapy-induced amenorrhea, FSH alone is unreliable and serial measurements or oophorectomy may be needed if aromatase inhibitor therapy is being considered 4, 7.